Sara Lodi

Joint Models for Estimating Determinants of Cognitive Decline in the Presence of Survival Bias.

Davis-Plourde KL, Mayeda ER, Lodi S, Filshtein T, Beiser A, Gross AL, Seshadri S, Glymour MM, Tripodis Y.

Epidemiology. 2022 May 01. 33(3):362-371. PMID: 35383644

Predicting counterfactual risks under hypothetical treatment strategies: an application to HIV.

Dickerman BA, Dahabreh IJ, Cantos KV, Logan RW, Lodi S, Rentsch CT, Justice AC, Hernán MA.

Eur J Epidemiol. 2022 Feb 22. PMID: 35190946

Stigma and ART initiation among people with HIV and a lifetime history of illicit drug use in Saint-Petersburg, Russia-A prospective cohort analysis.

Vetrova M, Lodi S, Rateau L, Patts G, Blokhina E, Palatkin V, Yaroslavtseva T, Toussova O, Bushara N, Bendiks S, Gnatienko N, Krupitsky E, Lioznov D, Samet JH, Lunze K.

Int J Drug Policy. 2022 04. 102:103600. PMID: 35134598

Concordance Between Point-of-Care Urine Ethyl Glucuronide Alcohol Tests and Self-Reported Alcohol Use in Persons with HIV in Uganda.

Alcover KC, Emenyonu NI, Fatch R, Kekibiina A, Marson K, Chamie G, Muyindike WR, Beesiga B, Kamya MR, Lodi S, Kane JC, Hahn JA, McDonell MG.

AIDS Behav. 2022 Feb 01. PMID: 35103888

Addressing intersectional stigma as a care barrier for HIV-positive people who inject drugs: Design of an RCT in St. Petersburg, Russia.

Rossi SL, Sereda Y, Luoma JB, Pavlov N, Toussova O, Vasileva J, Abramova K, Bendiks S, Kiriazova T, Vetrova M, Blokhina E, Krupitsky E, Lioznov D, Lodi S, Lunze K.

Contemp Clin Trials Commun. 2021 Dec. 24:100861. PMID: 34888430

Coronavirus Disease 2019 Vaccine Impact on Rates of Severe Acute Respiratory Syndrome Coronavirus 2 Cases and Postvaccination Strain Sequences Among Health Care Workers at an Urban Academic Medical Center: A Prospective Cohort Study.

Bouton TC, Lodi S, Turcinovic J, Schaeffer B, Weber SE, Quinn E, Korn C, Steiner J, Schechter-Perkins EM, Duffy E, Ragan EJ, Taylor BP, Miller N, Davidoff R, Hanage WP, Connor J, Pierre C, Jacobson KR.

Open Forum Infect Dis. 2021 Oct. 8(10):ofab465. PMID: 34646910

Projected long-term impact of the COVID-19 pandemic on hepatitis C outcomes in the United States: a modelling study.

Barocas JA, Savinkina A, Lodi S, Epstein RL, Bouton TC, Sperring H, Hsu HE, Jacobson KR, Schechter-Perkins EM, Linas BP, White LF.

Clin Infect Dis. 2021 Sep 09. PMID: 34499124

Enhancing Linkage to Hepatitis C Virus Treatment Following Pregnancy in Women Identified During Perinatal Care.

Epstein RL, Moloney C, Garfinkel J, Saia K, Wachman EM, Lodi S, Pelton SI.

Hepatol Commun. 2021 Sep. 5(9):1543-1554. PMID: 34510828

The Drinkers' Intervention to Prevent Tuberculosis (DIPT) trial among heavy drinkers living with HIV in Uganda: study protocol of a 2×2 factorial trial.

Lodi S, Emenyonu NI, Marson K, Kwarisiima D, Fatch R, McDonell MG, Cheng DM, Thirumurthy H, Gandhi M, Camlin CS, Muyindike WR, Hahn JA, Chamie G.

Trials. 2021 May 20. 22(1):355. PMID: 34016158

Time to SARS-CoV-2 PCR Clearance in Immunocompromising Conditions: Is Test-Based Removal From Isolation Necessary in Severely Immunocompromised Individuals?

Epstein RL, Sperring H, Hofman M, Lodi S, White LF, Barocas JA, Bouton TC, Xiao Y, Hsu HE, Miller NS, Linas BP, Marathe JG.

Open Forum Infect Dis. 2021 Jun. 8(6):ofab164. PMID: 34189164